Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

Chairwoman Reveals How AbbVie Wooed With Its Inversion Scheme

Bruker Corporation Discloses Plans To Sell California Unit And Lay Off Up To 250 Staffers

The Ingredients Of "All Natural Foods" Will Terrify You

Scientists To Be Given Compounds Discarded By Pharma Companies

Reckitt Benckiser Plc To Invest €100 Million In Its Consumer Health R&D Operations, Will Create 1,200 New Jobs

Marriage Of Diagnostics To New Therapies Breeds Biotech Winners

New Cambridge-Based Biotech VC Firm Emerges, Eyes $150 Million Fund

Losing Your Job Could Kill You, But Recessions Could Be Good For Your Health, Drexel University And University of Michigan Study

Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study

Newly Discovered Gut Virus Lives In Half The World's Population, San Diego State University Study

Choice Bias: A Quirky Byproduct Of Learning From Reward, Brown University Study

Pain And Itch May Be Signs Of Skin Cancer, s Chair Of Dermatology Reveals

Amgen, Bayer HealthCare's Nexavar Fails Late-Stage Breast Cancer Study

Massachusett's Ocular Therapeutix, Inc. Goes IPO At $13 A Share

Sources Reveal Reckitt Benckiser Plc Plans To Spinoff Virginia-Based Pharmaceutical Unit

Merck KGaA Eyes Southeast Asia Plants To Cut Costs

Allegations Of GlaxoSmithKline Corruption Spread To Syria

Incyte Corporation's Jakafi Fails to Provide RELIEF In Phase 3 Trial

AgeneBio Appoints Industry Leaders Patrick Lepore As Chairman Of The Board And Jerry Mclaughlin As President And Chief Executive Officer

Amgen Nervous As FDA Paves Way For Novartis AG To Copy Drug Neupogen

4 Ways Gilead Sciences, Inc.???s Earnings Will Impact Every American

What You Need To Know About The Listeria Fruit Recall

Sarepta Therapeutics Terminates Chief Science Officer As It Heads Toward Drug Approval

Do Drugmakers Use An FDA Safety Program To Thwart Generics?

San Diego Biotech Pfenex Inc. Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation

Paracetamol Does Not Work For Lower Back Pain, University of Sydney Study

More U.S. Teens' Report Using Human Growth Hormone

Seattle Biotech Immune Design Corporation Prices IPO At $12 Per Share, The Low End Of The Range

Indian Boy Has 232 Teeth Removed

Rosemary And Oregano Contain Diabetes-Fighting Compounds, Reveals

Study Claims Celgene Drug Can Drive HIV Out Of Hiding

Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range

Where Are The Unhappiest Cities In America? University of British Columbia Study

SoCal's Atara Biotherapeutics IPO Delayed By New Test Results

Centers for Disease Control and Prevention (CDC) Says Lab Director Behind Anthrax Mishap Resigns

Boehringer Ingelheim GmbH Withheld Evidence On Blockbuster Blood Thinner

GlaxoSmithKline CEO Has Bigger Problem Than China As Sales Drop

Poland Confirms Case Of African Swine Fever In Farm Pigs, Reveal

Hepatitis B Drug Rockets Gilead Sciences, Inc. Into The Big Leagues

Roche Profit Dented On Diagnostics Writedown

Celsion Corporation Announces Positive Interim Data Update From Its Phase 2 DIGNITY Study In Breast Cancer

Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site

Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial

India's Ipca Laboratories Halts Shipments To U.S. From Local Plant After FDA Concerns

Atox Bio Locks In $23 Million

Cubist Pharmaceuticals, Inc. Strikes Agreement With Competitor To Delay Generic Cubicin

Amgen Growth In Brazil Picks Up, Eyes Doubling Portfolio By 2020

Gilead Sciences, Inc., Strike Deal: New Opportunity For Indian Drugmakers

Ligand Pharmaceuticals Inc. Partner GlaxoSmithKline Announces Record Quarterly Promacta™/Revolade™ Revenue Of $92 Million

Bristol-Myers Squibb Company Appoints As India Country Head

Blueprint Medicines Appoints As Chief Executive Officer

Sysmex Corporation Appoints U.S. Subsidiary CEO To Executive Officer

Puma Biotechnology Shares Soar On Breast Cancer Drug Results

Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials

3 Quotes From Johnson & Johnson's Conference Call You Need To Read

Myriad RBM, Inc. To Downsize And Move Operations To Austin, Texas

Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition

Highest Paid Biopharma CEOs Not In The Triangle

HIV Rates Declining In U.S., Centers for Disease Control and Prevention (CDC) Reveals

Health Canada Approves Kane Biotech Inc.'s DispersinB® For Human Use

Eli Lilly and Company To Cut Up To 100 Indy Jobs, Send Some Work Overseas

Major Restructure At Allergan Inc. Amid Valeant Pharmaceuticals International Takeover Battle; To Cut 1,500 Jobs

Monsanto Company Should Lose Some Battles To Win The War Over GMOs

Taiho Pharmaceutical Invests US $30 Million In

Biogen, Inc. Second Quarter 2014 Revenues Increase 40% To $2.4 Billion; Company Raises Financial Guidance For The Year

Galena Biopharma Gives Sales Team Another Useless Product To Promote

Shire Share Price: Chief Executive Set For $10 Million 'Golden Hello'

ArmaGen Technologies, Inc. Licenses AGT-182 Rights To For Up To $225M

ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3

U.S. Gilead Sciences, Inc. Approves FDA's Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma

Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders, University of Iowa Study

Sofinnova Ventures Raises $500 Million Biotech Venture Fund

SD Researchers Top Compensation List

Zenith Epigenetics Appoints Julie Cherrington As President And CEO

Mela Sciences Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants

What Clinical Trials? Many Study Results Remain Under Wraps

ConMed Corporation Announces Leadership Transition

FDA Approves Eagle Pharmaceuticals' Ryanodex® For The Treatment Of Malignant Hyperthermia

Mylan Inc.'s Overseas Move Will Lower Tax Rate

Major Advance In Pipeline: Positive Topline Phase 3 Results For brivaracetam In Epilepsy Patients With Partial-Onset Seizures

University of Pittsburgh-Led Study Suggests Cystic Fibrosis Is Two Diseases, One Doesn???t Affect Lungs

FDA Grants Genentech???s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer

Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy

Moderate Alcohol Use Associated With Increased Risk For Atrial Fibrillation, Karolinska Institute Study

Alcohol Improves Your Sense Of Smell, Weizmann Institute of Science Study

Migraine Treatment Innovations Still Have Ways To Go

Young Women With A Heart Attack Continue To Fare Worse Than Men, Yale University School Of Medicine Study

Probiotics May Help People With High Blood Pressure, Griffith University Study

Johnson & Johnson CEO: We Have No Plans To Leave The U.S.

In Asthma, It's Not Just What You Smell, But What You Think You Smell, Monell Chemical Senses Center Study

New Research Links Bad Diet To Loss Of Smell, Florida State University Study

Baxter International, Inc. Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter

Antipsychotic Drugs Linked To Slight Decrease In Brain Volume, University of Cambridge Study

How Much Will Those Allergan Inc. Cost Cuts Really Help?

Neogen Corporation Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture

Candid Advice For Cash-Strapped Startups From A Biotech VC; Success At Lumena Pharmaceuticals

Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week

Brain Waves Show Learning To Read Doesn't End In Fourth Grade, Dartmouth College Study

Cardiff University Sheds New Light On Biology Underlying Schizophrenia

Agena Biosciences Appoints As Chief Executive Officer

Robert Kennedy's Dangerous Anti-Vaccine Activism

Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO

SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus

Large Allergan Inc. Investor Sells Most Of Stake

Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?

Cancer Genetics, Inc. Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million

Anacor Pharmaceuticals, Inc. Inks Exclusive Deal With Sandoz, Inc. For Kerydin; To Receive Upfront $40 Million

Amgen Abruptly Puts 70 People On Leave, Cuts Jobs

Avid Cyclists Could Have Higher Prostate Cancer Risk, University College London Study

Drive to Add FDA Drug Police In India Delayed

Healing The Heart With Fat?

Consuming Probiotics For A Month Helps Diminish Fat Accumulation In The Liver, University of Granada Study

Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing

National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, And Singapore General Hospital Scientists Discover Genetic Cause Of Common Breast Tumours In Women

Phosphagenics Limited Completes First Tranche of A $19.3 Million Capital Raising

Fall From Grace: BioSpace Readers Sound Off On Novartis AG And Other Pharma Layoffs

National Institutes of Health (NIH) System To Monitor Emerging Drug Trends

StemCells Inc. Announces Closing Of $20 Million Offering

Arno Therapeutics Appoints As Interim Chief Executive Officer And As Chief Operating Officer

Roche CEO Plans To Steer Clear Of Big Acquisitions

Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares

Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers

AbbVie Finally Clinches For $54 Billion

Four Cases Of Life-Threatening Plague Found In Colorado

222


    Read more..